Lidocaine cage (Cathejell with Lidocaine)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceLidocaine + ChlorhexidineLidocaine + Chlorhexidine
Similar drugsTo uncover
  • Instillagel®
    gel locally 
    Farco-Pharma GmbH     Germany
  • Lidocaine cage
    gel locally 
    Pharmacitis Factory Fabrik Montavit Gesellschaft mbH.     Austria
  • Lidocaine Asept
    spray locally 
    BIOGEN NPC, OAO     Russia
    • Dosage form: & nbspgel for topical application
    Composition:

    100 g contains:

    active substances:

    lidocaine hydrochloride ........................ 2.00 g

    chlorhexidine dihydrochloride ................ 0.05 g

    Excipients:

    hyethelose (hydroxyethyl cellulose) ...... 1.50 g

    glycerol ........................................ 20.00 g

    water for injection ....................... up to 100.00 g

    Description:Transparent, colorless or almost colorless gel.
    Pharmacotherapeutic group:Antiseptic + local anesthetic
    ATX: & nbsp

    N.01.B.B.52   Lidocaine in combination with other drugs

    Pharmacodynamics:

    Combined drug, which has antiseptic and local anesthetic effect. Chlorhexidine - antimicrobial drug, acting on gram-positive and gram-negative microorganisms, yeast, dermatophytes. Effective against Gram-positive and Gram-negative bacteria - Treponema spp., Neisseria gonorrhoeae, Trichomonas spp., Chlamydia spp., Ureaplasma spp. Keeps activity (although somewhat reduced) in the presence of blood, pus, various secrets and organic substances.

    Lidocaine is a local anesthetic.

    Antimicrobial action and adequate anesthesia develop 5-10 min after application of the drug.

    The water-soluble clear gel provides a clear optical view and has a lubricating effect for various endoscopic procedures.

    Indications:

    Prevention of infection, anesthesia in operative and diagnostic endoscopic interventions in children and adults in urology, gynecology, proctology, all forms of endoscopy, replacement of fistula catheters, intubation.

    It is used in complex therapy for relief of symptoms of inflammation in (accompanied by pain syndrome) of the mucous membrane of the urethra, vagina, cervical canal and rectum.

    Contraindications:Hypersensitivity.
    Carefully:

    Pregnancy (first trimester).

    In the case of lactation, refrain from breastfeeding for 12 hours after use.

    Dosing and Administration:

    For a slow installation before the introduction of the instruments (by a doctor or specially trained personnel) it is necessary:

    - Unfold the blister, removing the paper from the transparent body (if possible only until the waist);

    - break off the tip without significant effort (if possible still in the package). It should be ensured that the tip is completely removed, in order to avoid damage to the mucosa. To facilitate the introduction, it is recommended to pre-squeeze a drop of gel;

    - installation by light pressure on the corrugated syringe. After emptying the syringe, it must be kept in a compressed state until seizure.

    - It is recommended to administer the instruments 5-10 minutes after the gel instillation.

    Side effects:With increased sensitivity, allergic reactions are possible (allergic dermatitis, skin rash, angioedema), burning at the place of application.
    Overdose:

    Symptoms (with systemic action of lidocaine in cases of severe damage to the urethra): bradycardia, convulsions, collapse.

    Treatment: with bradycardia - beta-adrenostimulators, with cramps-barbiturates or short-acting muscle relaxants, in case of collapse - epinephrine or dopamine is administered intravenously.

    Interaction:Avoid joint use with iodine preparations. MAO inhibitors enhance the local anesthetic effect of lidocaine.Incompatible with soap, as well as detergents containing an anionic group (saponins, sodium lauryl sulfate, sodium carboxymethyl cellulose). Compatible with drugs containing a cationic group (benzalkonium chloride).
    Special instructions:

    The drug is sterile and is intended for single administration.

    In the case of lactation, refrain from breastfeeding for 12 hours after use.

    Regional and local anesthesia should be carried out by experienced specialists in an appropriately equipped room with availability of ready-to-use equipment and preparations necessary for cardiac monitoring and resuscitation. Personnel performing anesthesia should be qualified and trained in the technique of performing anesthesia, should be familiar with the diagnosis and treatment of systemic toxic reactions, adverse events and reactions, and other complications.

    Form release / dosage:
    Gel for topical application.
    Packaging:

    For 12.5 grams in a disposable polypropylene corrugated syringe with an elongated and breakable tip.The syringe is placed in a blister consisting of two parts: the upper one is a polypropylene film that can withstand steam sterilization, the lower one is a paper one.

    1. Blister together with instructions for use are placed in a cardboard box.

    2. Packing for hospital: 5 or 25 blisters are placed in a cardboard box, on the side of which the text of instruction for use is printed.

    Storage conditions:In the dark place at a temperature of + 15 to + 25 ° C. Keep out of the reach of children.
    Shelf life:5 years. Do not use after the expiry date printed on the package.
    Terms of leave from pharmacies:On prescription
    Registration number:П N012477 / 01
    Date of registration:18.07.2008 / 24.06.2014
    Expiration Date:Unlimited
    The owner of the registration certificate:Pharmacitis Factory Fabrik Montavit Gesellschaft mbH.Pharmacitis Factory Fabrik Montavit Gesellschaft mbH. Austria
    Manufacturer: & nbsp
    Representation: & nbspPharmacistice Factory Montavit Gesmb.b.H.Pharmacistice Factory Montavit Gesmb.b.H.
    Information update date: & nbsp26.12.2017
    Illustrated instructions
      Instructions
      Up